(BCRX) Biocryst Pharmaceuticals Weekly charts technical analysis
(BCRX) Biocryst Pharmaceuticals Weekly charts technical analysis Weekly analysis of Biocryst Pharmaceuticals | Buy/Sell Biocryst Pharmaceuticals
Biocryst Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Biocryst Pharmaceuticals is 2411590
| Date | Closing Price | Open | High | Low | Volume |
| 11 Thu Sep 2025 | 8.07 | 8.26 | 8.31 | 7.93 | 8.932 Mn |
| 05 Fri Sep 2025 | 8.27 | 8.37 | 8.47 | 8.02 | 11.033 Mn |
| 29 Fri Aug 2025 | 8.31 | 8.46 | 8.49 | 8.29 | 2.314 Mn |
| 29 Fri Aug 2025 | 8.31 | 8.60 | 8.68 | 8.27 | 10.049 Mn |
| 22 Fri Aug 2025 | 8.56 | 8.38 | 8.62 | 8.18 | 10.001 Mn |
| 15 Fri Aug 2025 | 8.37 | 8.20 | 8.64 | 8.08 | 13.052 Mn |
| 08 Fri Aug 2025 | 8.30 | 8.62 | 8.69 | 8.26 | 10.999 Mn |
| 01 Fri Aug 2025 | 7.95 | 8.60 | 8.60 | 7.91 | 23.205 Mn |
| 25 Fri Jul 2025 | 8.55 | 8.63 | 8.74 | 8.40 | 14.881 Mn |
| 18 Fri Jul 2025 | 8.61 | 8.78 | 9.05 | 8.44 | 14.708 Mn |
Indicators analysis of Biocryst Pharmaceuticals (BCRX)
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Biocryst Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Biocryst Pharmaceuticals in short term and the sell signal is strong.
Biocryst Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Biocryst Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Biocryst Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.31 and Biocryst Pharmaceuticals (BCRX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biocryst Pharmaceuticals (BCRX) stock. Volume based technical analysis of Biocryst Pharmaceuticals (BCRX) stock is negative.
Biocryst Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Weekly charts
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Biocryst Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Biocryst Pharmaceuticals in short term and the sell signal is strong.
Biocryst Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Biocryst Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Biocryst Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.31 and Biocryst Pharmaceuticals (BCRX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biocryst Pharmaceuticals (BCRX) stock. Volume based technical analysis of Biocryst Pharmaceuticals (BCRX) stock is negative.
Biocryst Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.